Jun 10, 2024 | Diabetes Business, Eating, Featured, Research News, Technology Updates
JDRF Rebrands as Breakthrough T1D to Accelerate Type 1 Research and Advocacy by Daniel Trecroci for BeyondType1.org, 4 June 2024. On June 4, 2024, the Juvenile Diabetes Research Foundation (JDRF) announced that Breakthrough T1D was the new name for the...
Jun 3, 2024 | Diabetes Business, Featured, Foods, Research News, Technology Updates
The Modular Medical MODD1 insulin pump. What do we know? by Tim Street for Diabettech.com, 31 May 2024. Modular Medical recently submitted their new pump system to the FDA for approval. It’s described as: “Effortless Insulin Delivery Made Possible.”...
May 28, 2024 | Advocacy, Diabetes Business, Featured, Foods, Podcasts, Research News, Technology Updates
FDA approves hybrid closed-loop insulin delivery app from CamDiab by Sean Whooley for DrugDelieveryBusiness.com, 24 May 2024. CamDiab announced today that the FDA granted authorization for its CamAPS FX advanced adaptive closed-loop artificial pancreas app. CamAPS FX,...
May 20, 2024 | Advocacy, Diabetes Business, Featured, LOOPing, Podcasts, Research News, Technology Updates, Videos
Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin by Stacey Simms for Diabetes-Connections.com, 16 April 2024. This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that...
May 13, 2024 | Diabetes Business, Featured, Pets, Research News, Technology Updates
FDA Warns on (Tandem) Insulin Pump Problem by Kristen Monaco for MedPageToday.com, 8 May 2024. Mobile app glitch may cause t:slim X2 insulin pump battery to drain sooner than expected. A mobile app used with an insulin pump that led to 224 injuries was recalled...
May 6, 2024 | Diabetes Business, Featured, Foods, Research News, Technology Updates
Fully-implantable CGM receives FDA authorization for integration with insulin pumps by Jill Rollet for Healio.com/endocrinology, 30 April 2024. The Eversense E3 CGM (Senseonics Holdings and Ascensia Diabetes Care) received authorization to be marketed as an integrated...
Apr 29, 2024 | Advocacy, Diabetes Business, Featured, Foods, Research News
Introducing Cadisegliatin, a New Drug in the Type 1 Diabetes Pipeline by Ross Wollen for DiabetesDaily.com, 26 April 2024. Cadisegliatin, an investigative therapy currently entering phase 3 trials, could be the next important drug, after insulin, indicated for Type 1...
Apr 22, 2024 | Diabetes Business, Featured, Research News, Spotlight
JDRF Statement and Update on Insulin Shortage by JDRF.org/press-releases, April 2024. JDRF is aware that, unfortunately, individuals are having trouble filling their prescriptions for 10mL Humalog, 10mL Insulin Lispro, and 10mL Novolog vials. It is unacceptable that...
Apr 15, 2024 | A Little Humor, Advocacy, Diabetes Business, Research News, Technology Updates
Lilly’s Carelessness in Discontinuing 3 mL vials of Humalog Causes Shortages in 10 mL vials of Humalog + Unbranded Lispro by Scott Strumello for blog.sstrumello.com, 9 April 2024. In mid-March 2024, the JDRF shared news about how Eli Lilly & Company,...
Apr 8, 2024 | Advocacy, Diabetes Business, Featured, Foods, Research News, Technology Updates, Videos
The next-gen implantable bioartificial pancreas by Bernard Banga for Medical-Technology.nridigital.com, 22 September 2023. A team from MIT, in collaboration with researchers from Boston Children’s Hospital, has developed a novel implantable device. The...